I'm LongbridgeAI, I can summarize articles.Health care stocks rose due to safe-haven demand and rotation into defensive sectors. UnitedHealth Group shares gained over 3%, driven by reduced fears about its business model. Drug makers also saw gains as tech sector volatility increased. AstraZeneca rose 2.9% after announcing a partnership with AI startup Insitro for disease research, valued up to $1.5 billion.
Health-care companies rose as a rotation into defensive health insurers and Big Pharma companies continued.
Shares of UnitedHealth Group rose by more than 3%, and are now up by more than 8% during the last month as fears about the company's business model subsided.
Shares of drug makers also gained as artificial-intelligence jitters struck the tech sector.
Shares of AstraZeneca rose 2.9% to $166.68 after the British drug maker said it was teaming up with startup Insitro to tap AI for disease research in a deal valued at as much as $1.5 billion.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
October 15, 2026 17:40 ET (21:40 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.